TL 385 TL 385 (Terazosin Hydrochloride 5 mg)
Pill with imprint TL 385 TL 385 is Orange, Capsule-shape and has been identified as Terazosin Hydrochloride 5 mg. It is supplied by Cadista.
Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug classes alpha-adrenoreceptor antagonists, antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TL 385 TL 385
Terazosin Hydrochloride
- Imprint
- TL 385 TL 385
- Strength
- 5 mg
- Color
- Orange
- Size
- 16.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Alpha-adrenoreceptor antagonists, Antiadrenergic agents, peripherally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cadista
- Inactive Ingredients
-
gelatin,
lactose monohydrate,
magnesium stearate,
sodium lauryl sulfate,
titanium dioxide,
corn starch,
silicon dioxide,
D&C Yellow No. 10,
D&C Red No. 28,
FD&C Red No. 40
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 59746-0385 | Jubilant Cadista Pharmaceuticals Inc. |
| 67544-0563 | Prepak Systems Inc. (repackager) |
More about terazosin
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (48)
- Drug images
- Pricing & coupons
- En español
- Drug class: alpha-adrenoreceptor antagonists
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.